Shandong builds a 'blue drug store', the world's largest alginate production
The reporter learned from the "Thirteenth Five-Year" Achievement Tour Series press conference held by the Shandong Provincial Government Information Office on the afternoon of November 30 that Shandong has built a "blue drug store" and has the world's largest alginate production capacity.
Zhang Jiandong, a member of the Party Leadership Group of the Shandong Provincial Department of Natural Resources and Director of the Provincial Oceanic Bureau, introduced that the marine biomedical industry is one of the most potential strategic emerging industries in my country, and its compound growth rate is twice the growth rate of marine GDP. Shandong is a major province in the marine biopharmaceutical industry, with an output value of more than 20 billion yuan, accounting for about half of the country's total. During the "13th Five-Year Plan" period, Shandong has increased its efforts in research and development of marine innovative drugs, established the "China Blue Drug Bank Development Fund" with a total scale of 5 billion yuan, and established the Shandong Provincial Marine Drug Manufacturing Innovation Center. The "Blue Medicine Bank" has built six product development platforms including modern marine medicine and modern marine Chinese medicine. The domestically-made new drug GV971 for Alzheimer's disease independently developed by the academician Guan Huashi's team was approved for marketing, becoming the world's 14th (China's second) marine drug; the "Blue Drug Library" key new drug project, the anti-tumor drug BG136, is about to be launched Clinical declaration. Qingdao City has built the world's largest seaweed biological product industrial base, with the world's largest alginate production capacity; Zhenghaier Pharmaceutical is the only national marine drug pilot plant in China; Yantai Dongcheng Pharmaceutical has become the world's largest chondroitin sulfate raw material Manufacturer, the only domestic supplier of chondroitin sulfate injections.
Zhang Jiandong said that at a new starting point, he will continue to gather the majestic forces of the construction of a strong marine province, cut the waves and map the sea, strive to create a new situation in the construction of a strong marine province, and make Shandong's contribution to the construction of a strong marine country!
2026-10-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
EU Authorises Propionic Acid and Its Salts as Feed Additives Until 2035
-
U.S. Onshoring Debate Exposes API Raw-Material Gap
-
Strides Pharma Reports Strong Q2 as Net Profit Surges 82%
-
IPEC Updates Excipient Qualification Guidance
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
Aldi Expands Its Ingredient Ban
-
Singapore Suspends Poultry Imports from Avian Flu-Affected Areas in Japan
-
UK Proposes Sharp Increase in MRL for Flubendiamide in Tea
Recommend Reading
-
EFSA Confirms Safety of Triacylglycerol Lipase for Expanded Food Uses
-
EFSA Finds L-Cysteine Feed Additives Safe for All Animal Species
-
EFSA Renews Authorisation of Inositol for Use in Fish and Crustacean Feed
-
EFSA Reports Avian Influenza Situation in Europe and Human Cases in Asia
-
Canada Launches Re-Evaluation of Herbicide Iodosulfuron-Methyl-Sodium
-
Macro Factors Drive Costs, Shandong Cyclohexanone Prices Up 14.48% in 5 Days
-
Styrene Market Fluctuates Narrowly This Week (Aug. 24–Aug. 28)
-
Sulfate of Ammonia Market Prices Continue to Rise (3.1-3.5)
-
August TDI Market Fluctuates and Declines in China
-
Cost Support: Adipic Acid Sees Rising Prices